FMC Corporation

FMC Corporation

FMC Corporation traces its roots to 1883, when John Bean invented a continuous spray pump for combating San Jose scale in California orchards. The company spent more than a century accumulating a sprawling portfolio — lithium, hydrogen peroxide, soda ash, food ingredients — before CEO Pierre Brondeau executed a series of divestitures and the critical 2017 swap with DuPont that shed FMC's health and nutrition business in exchange for DuPont's crop-protection assets and $1.2 billion in cash. Today the firm operates exclusively in agricultural sciences. The company's capital deployment focuses on three categories: synthetic crop-protection chemistries (insecticides, herbicides, fungicides), a biologicals platform anchored by proprietary peptides and microbial products, and precision-agriculture technologies that layer application forecasting onto its active-ingredient portfolio. FMC holds commanding positions in diamide insecticides — Rynaxypyr and Cyazypyr — which generated over $1.5 billion in annual revenue at peak patent coverage (per the firm's 2023 10-K). Geographic exposure skews toward Latin America and Asia, with Brazil, India, and the US collectively driving more than half of segment revenue. FMC operates corporate venture capital through FMC Ventures, which targets early-stage companies in soil health, robotics, and digital agronomy. Positions include investments in Trace Genomics, Terramera, and Guardian Agriculture. The corporation also maintains a defined-benefit pension plan and a self-insured captive structure. In November 2023, FMC announced a realignment into two geographic operating units — North America/Latin America and Asia/EMEA — consolidating prior regional layers under Executive Vice President Ronaldo Pereira (per the firm, November 2023). FMC's structural differentiator is its simultaneous operation as a publicly traded industrial, an active portfolio reallocator, and a direct investor in agricultural start-ups. Unlike most corporate venture arms housed inside conglomerates, FMC Ventures invests from a balance sheet that directly manufactures and distributes the chemistries its portfolio companies might eventually complement or disrupt. That vertical integration, paired with a decisional cadence that has seen FMC exit lithium, alkali chemicals, and food ingredients entirely in a single decade, makes it one of the few S&P 500 components with a repeatable playbook for wholesale business-model migration.